These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30020570)

  • 21. Unlicensed and off-label use of medicines at a neonatology clinic in Italy.
    Dell'Aera M; Gasbarro AR; Padovano M; Laforgia N; Capodiferro D; Solarino B; Quaranta R; Dell'Erba AS
    Pharm World Sci; 2007 Aug; 29(4):361-7. PubMed ID: 17351821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Investigation of Prescription Indicators and Trends Among General Practitioners and Specialists From 2005 to 2015 in Kerman, Iran.
    Masoud A; Noori Hekmat S; Dehnavieh R; Haj-Akbari N; Poursheikhali A; Abdi Z
    Int J Health Policy Manag; 2018 Sep; 7(9):818-827. PubMed ID: 30316230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Medicines Repurposing Program - a critical perspective.
    Ghinea N
    Aust Health Rev; 2024 Jun; 48(3):259-261. PubMed ID: 38710479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.
    Wong J; Motulsky A; Abrahamowicz M; Eguale T; Buckeridge DL; Tamblyn R
    BMJ; 2017 Feb; 356():j603. PubMed ID: 28228380
    [No Abstract]   [Full Text] [Related]  

  • 25. Off-label prescribing for children with chronic diseases in Nigeria; findings and implications.
    Oshikoya KA; Oreagba IA; Godman B; Fadare J; Orubu S; Massele A; Senbanjo IO
    Expert Opin Drug Saf; 2017 Sep; 16(9):981-988. PubMed ID: 28627939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A survey of medicine use in children and adolescents in Austria.
    Rauch E; Lagler FB; Herkner H; Gall W; Sauermann R; Hetz S; Male C
    Eur J Pediatr; 2018 Oct; 177(10):1479-1487. PubMed ID: 29978258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Off-label and unlicensed use of medicinal products in the neonatal setting in the Slovak Republic.
    Schweigertova J; Durisova A; Dolnikova D; Ondriasova E; Balazova M; Slezakova V; Kuzelova M
    Pediatr Int; 2016 Feb; 58(2):126-31. PubMed ID: 26256925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Safe administration of medicines: learning from our mistakes].
    Burger DM; van der Cruijsen MWL; Schim van der Loeff R
    Ned Tijdschr Geneeskd; 2017; 161():D2183. PubMed ID: 29171378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Training the next generation of providers in addiction medicine.
    Rasyidi E; Wilkins JN; Danovitch I
    Psychiatr Clin North Am; 2012 Jun; 35(2):461-80. PubMed ID: 22640766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Respiratory drugs prescribed off-label among children in the outpatient clinics of a hospital in Malaysia.
    Mohamad NF; Mhd Ali A; Mohamed Shah N
    Int J Clin Pharm; 2015 Feb; 37(1):127-32. PubMed ID: 25488318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unlicensed and off-label prescription of respiratory drugs to children.
    't Jong GW; Eland IA; Sturkenboom MC; van den Anker JN; Strickerf BH
    Eur Respir J; 2004 Feb; 23(2):310-3. PubMed ID: 14979509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Standardization of names in prescriptions of traditional Chinese medicines].
    Li CF; Zhang YJ; Fan DH; Zhang MJ; Bai X; Yang WH; Qi SY; Zhang ZJ; Xue CM; Mao LY; Cao JL
    Zhongguo Zhong Yao Za Zhi; 2017 Jan; 42(1):198-202. PubMed ID: 28945049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions.
    Polamreddy P; Gattu N
    Drug Discov Today; 2019 Mar; 24(3):789-795. PubMed ID: 30513339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation.
    Lindell-Osuagwu L; Hakkarainen M; Sepponen K; Vainio K; Naaranlahti T; Kokki H
    J Clin Pharm Ther; 2014 Apr; 39(2):144-53. PubMed ID: 24329556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012.
    Vilhelmsson A; Davis C; Mulinari S
    PLoS Med; 2016 Jan; 13(1):e1001945. PubMed ID: 26812151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of medicines use pattern using World Health Organization's Prescribing, Patient Care and Health facility indicators in selected health facilities in eastern Ethiopia.
    Bilal AI; Osman ED; Mulugeta A
    BMC Health Serv Res; 2016 Apr; 16():144. PubMed ID: 27106610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medication safety at the interface: evaluating risks associated with discharge prescriptions from mental health hospitals.
    Keers RN; Williams SD; Vattakatuchery JJ; Brown P; Miller J; Prescott L; Ashcroft DM
    J Clin Pharm Ther; 2015 Dec; 40(6):645-54. PubMed ID: 26534824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Off-Label Prescription of Psychopharmacological Drugs in Child and Adolescent Psychiatry.
    Braüner JV; Johansen LM; Roesbjerg T; Pagsberg AK
    J Clin Psychopharmacol; 2016 Oct; 36(5):500-7. PubMed ID: 27529772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Off-label prescription of genetically modified organism medicines in europe: emerging conflicts of interest?
    Schagen FH; Hoeben RC; Hospers GA
    Hum Gene Ther; 2014 Oct; 25(10):893-6. PubMed ID: 25268158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Off-label use in psychiatry].
    Weih M; Thürauf N; Bleich S; Kornhuber J
    Fortschr Neurol Psychiatr; 2008 Jan; 76(1):7-13. PubMed ID: 17899492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.